Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Muaatamarulain Mustangin"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
p40 Immunohistochemistry Is an Excellent Marker in Primary Lung Squamous Cell Carcinoma
Khairunisa Ahmad Affandi, Nur Maya Sabrina Tizen, Muaatamarulain Mustangin, Reena Rahayu MdReena Rahayu Md Zin
J Pathol Transl Med. 2018;52(5):283-289.   Published online August 31, 2018
DOI: https://doi.org/10.4132/jptm.2018.08.14
  • 18,539 View
  • 302 Download
  • 28 Web of Science
  • 28 Crossref
AbstractAbstract PDF
Background
Lung cancer is the third most common cancer worldwide. With major advances in the molecular testing of lung cancers and the introduction of targeted therapies, the distinction between adenocarcinoma and squamous cell carcinoma as well as pathologic subtyping has become important. Recent studies showed that p40 is highly specific for squamous and basal cells and is superior to p63 for diagnosing lung squamous cell carcinoma. The aim of this study was to evaluate the use of p40 immunohistochemical stain in the diagnosis of non-small cell lung carcinoma and its potential to replace current p63 antibody as the best immunohistochemical squamous marker.
Methods
Seventy formalin-fixed paraffin-embedded cases previously diagnosed as primary lung squamous cell carcinoma (n = 35) and lung adenocarcinoma (n = 35) from January 2008 to December 2016 were retrieved. The results of tumour cell immunoreactivity for p40 and p63 antibodies in lung squamous cell carcinoma and lung adenocarcinoma were compared.
Results
p40 was expressed in 27 cases of lung squamous cell carcinoma (77.1%). All cases of lung adenocarcinoma (35/35, 100%) were negative for p40. p63 expression was positive in 30 cases of lung squamous cell carcinoma (85.7%) and 13 cases of lung adenocarcinoma (37.1%). Reactivity for both p40 and p63 in lung squamous cell carcinoma was strong and diffuse, whereas variable reactivity was observed in lung adenocarcinoma.
Conclusions
p40 is an excellent marker for distinguishing lung squamous cell carcinoma from adenocarcinoma, and p40 expression is equivalent to p63 expression in lung squamous cell carcinoma.

Citations

Citations to this article as recorded by  
  • Lack of imbalance between the master regulators TTF1/NKX2-1 and ΔNp63/p40 implies adverse prognosis in non-small cell lung cancer
    Martina Vescio, Matteo Bulloni, Giuseppe Pelosi, Linda Pattini
    Scientific Reports.2024;[Epub]     CrossRef
  • Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer
    Xinyuan Tong, Ayushi S. Patel, Eejung Kim, Hongjun Li, Yueqing Chen, Shuai Li, Shengwu Liu, Julien Dilly, Kevin S. Kapner, Ningxia Zhang, Yun Xue, Laura Hover, Suman Mukhopadhyay, Fiona Sherman, Khrystyna Myndzar, Priyanka Sahu, Yijun Gao, Fei Li, Fuming
    Cancer Cell.2024; 42(3): 413.     CrossRef
  • Common practice issues in pulmonary cytology/small biopsy: Diagnostic pitfalls and appropriate use of immunohistochemical stains
    Jessie Xiong, Erik Polsdofer, Jian Jing
    Human Pathology Reports.2024; 36: 300735.     CrossRef
  • Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non–Small Cell Lung Cancer
    Alessandra Rigamonti, Marika Viatore, Rebecca Polidori, Daoud Rahal, Marco Erreni, Maria Rita Fumagalli, Damiano Zanini, Andrea Doni, Anna Rita Putignano, Paola Bossi, Emanuele Voulaz, Marco Alloisio, Sabrina Rossi, Paolo Andrea Zucali, Armando Santoro, V
    Cancer Research.2024; 84(7): 1165.     CrossRef
  • Advances in combined neuroendocrine carcinoma of lung cancer
    Zesen Han, Fujun Yang, Fang Wang, Huayu Zheng, Xiujian Chen, Hongyu Meng, Fenglei Li
    Pathology and Oncology Research.2024;[Epub]     CrossRef
  • Evolving Precision First-Line Systemic Treatment for Patients with Unresectable Non-Small Cell Lung Cancer
    Tianhong Li, Weijie Ma, Ebaa Al-Obeidi
    Cancers.2024; 16(13): 2350.     CrossRef
  • Antibody-Conjugated Nanodiamond Enzyme for Targeted Non-Small-Cell Lung Cancer by Regulating Oxidative Stress
    Xiaoying Guan, Jingwen Yang, Ziying Liu, Guowei Yang, Xiumei Tian
    ACS Applied Nano Materials.2024; 7(20): 23670.     CrossRef
  • Multifocal Pulmonary Opacities in an Elderly Smoker
    Patton C McClelland, Zachary Jarrett, Christian C Lamb, Mateo Houle
    Cureus.2024;[Epub]     CrossRef
  • Clonal dynamics and Stereo-seq resolve origin and phenotypic plasticity of adenosquamous carcinoma
    Ruiying Zhao, Yunhua Xu, Yedan Chen, Jiajun Zhang, Fei Teng, Sha Liao, Shengnan Chen, Qian Wu, Chan Xiang, Jiaohui Pang, Zhanxian Shang, Jikai Zhao, Hairong Bao, Hua Bao, Yang Shao, Shun Lu, Yuchen Han
    npj Precision Oncology.2023;[Epub]     CrossRef
  • Keratin 5 in Lung Cancer Specimens: Comparison of Four Antibody Clones and KRT5 mRNA-ISH
    Christian Thomsen, Laura Blok-Husum, Jeanette Bæhr Georgsen, Torben Steiniche, Mogens Vyberg
    Applied Immunohistochemistry & Molecular Morphology.2023; 31(6): 347.     CrossRef
  • Carcinoma of unknown primary (CUP): an update for histopathologists
    Katie Beauchamp, Bruce Moran, Timothy O’Brien, Donal Brennan, John Crown, Kieran Sheahan, Maura Bríd Cotter
    Cancer and Metastasis Reviews.2023; 42(4): 1189.     CrossRef
  • Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment
    Juan Carlos Restrepo, Diana Dueñas, Zuray Corredor, Yamil Liscano
    Cancers.2023; 15(13): 3474.     CrossRef
  • Kallikrein-related peptidase 13 expression and clinicopathological features in lung squamous cell carcinoma
    Ryusuke Sumiya, Kazuhiko Yamada, Teruki Hagiwara, Satoshi Nagasaka, Hideki Miyazaki, Toru Igari, Yuki Kawamura
    Molecular and Clinical Oncology.2023;[Epub]     CrossRef
  • Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions
    Priyanka Sahu, Chantal Donovan, Keshav Raj Paudel, Sophie Pickles, Vrushali Chimankar, Richard Y. Kim, Jay C. Horvart, Kamal Dua, Antonio Ieni, Francesco Nucera, Helle Bielefeldt-Ohmann, Sarah Mazilli, Gaetano Caramori, J. Guy Lyons, Philip M. Hansbro
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Intraosseous clear cell mucoepidermoid carcinoma: A case report and evaluation
    Adesh S. Manchanda, Ramandeep S. Narang, Komaldeep K. Sandhu
    Journal of Oral and Maxillofacial Pathology.2023; 27(4): 780.     CrossRef
  • A targeted expression panel for classification, gene fusion detection and PD-L1 measurements – Can molecular profiling replace immunohistochemistry in non-small cell lung cancer?
    Anita Tranberg Simonsen, Amalie Utke, Johanne Lade-Keller, Lasse Westphal Thomsen, Torben Steiniche, Magnus Stougaard
    Experimental and Molecular Pathology.2022; 125: 104749.     CrossRef
  • Basal cell carcinoma arising in association with maxillary odontogenic keratocyst in a patient with Gorlin-Goltz syndrome
    Mutsuki Kawabe, Yoshitane Tsukamoto, Shohei Matuo, Shuji Kanda, Susumu Hashitani
    Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.2022; 34(3): 333.     CrossRef
  • Cutaneous Metastases from Thymic Carcinoma Primary Tumor: A Rare Case
    Eva Krishna Sutedja, Trustia Rizqandaru, Kartika Ruchiatan, Endang Sutedja
    International Medical Case Reports Journal.2022; Volume 15: 293.     CrossRef
  • Primary nonkeratinizing squamous cell carcinoma of the scapular bone: A case report
    Yang Li, Jian-Lin Zuo, Jin-Shuo Tang, Xian-Yue Shen, Sheng-Hao Xu, Jian-Lin Xiao
    World Journal of Clinical Cases.2021; 9(4): 976.     CrossRef
  • Survival-associated N6-adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification
    Jialin Qu, Li Wang, Man Jiang, Zhimin Wei, Guangming Fu, Xiaochun Zhang
    BMC Cancer.2021;[Epub]     CrossRef
  • Pulmonary adenomyoma presenting as a right cardiophrenic angle mass
    Osigbemhe Iyalomhe, Sam Sadigh, Charuhas Deshpande, Leslie Litzky, Anna Moran, Scott Simpson
    Radiology Case Reports.2020; 15(5): 502.     CrossRef
  • Head-to-Head Comparison of p63 and p40 in Non-Neuroendocrine Carcinomas of the Tubal Gut
    Ahmed M. Bakhshwin, Ilyssa O. Gordon, Kathryn Bock Brown, Xiuli Liu, Daniela S. Allende
    International Journal of Surgical Pathology.2020; 28(8): 835.     CrossRef
  • Greater specificity of p40 compared with p63 in distinguishing squamous cell carcinoma from adenocarcinoma in effusion cellblocks
    Nah Ihm Kim, Ji Shin Lee
    Cytojournal.2020; 17: 13.     CrossRef
  • Incidental Thyroid Mass in a Patient With Oropharyngeal Squamous Cell Carcinoma
    Kinneri Mehta, Misha Movahed-Ezazi, Akshay V. Patel
    JAMA Otolaryngology–Head & Neck Surgery.2020; 146(9): 859.     CrossRef
  • Three dimensional texture analysis of noncontrast chest CT in differentiating solitary solid lung squamous cell carcinoma from adenocarcinoma and correlation to immunohistochemical markers
    Rui Han, Roshan Arjal, Jin Dong, Hong Jiang, Huan Liu, Dongyou Zhang, Lu Huang
    Thoracic Cancer.2020; 11(11): 3099.     CrossRef
  • The role of the immunohistochemical marker p40 in the differential diagnosis of adenocarcinoma and nonkeratinizing squamous cell cancer of the lung
    E.M. Olyushina, M.M. Byakhova, L.E. Zavalishina, Yu.Yu. Andreeva, A.B. Semenova, G.A. Frank
    Arkhiv patologii.2020; 82(5): 50.     CrossRef
  • Role of Immunocytochemistry in the Cytological Diagnosis of Pulmonary Tumors
    Jasna Metovic, Luisella Righi, Luisa Delsedime, Marco Volante, Mauro Papotti
    Acta Cytologica.2020; 64(1-2): 16.     CrossRef
  • Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies
    Sandra P. Nunes, Francisca Diniz, Catarina Moreira-Barbosa, Vera Constâncio, Ana Victor Silva, Júlio Oliveira, Marta Soares, Sofia Paulino, Ana Luísa Cunha, Jéssica Rodrigues, Luís Antunes, Rui Henrique, Carmen Jerónimo
    Journal of Clinical Medicine.2019; 8(9): 1500.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP